Program Chair: Indira Guleria, PhD, D(ABHI), CABP(H) – BIDMC and Harvard Medical School
### @@@ Kate Rochlin, PhD (she/her/hers) – In8Bio ### 2438870###Speaker###COO###In8Bio###Speaker: Kate Rochlin, PhD (she/her/hers) – In8Bio
### she/her/hers @@@ Rafet Basar, MD – MD Anderson ### 2480994###Speaker###Assistant Professor###MD Anderson###Speaker: Rafet Basar, MD – MD Anderson
### AM24-TU-01-LProgram Chair: Isra Levy, MB,BCh, MSc, FRCPC (he/him/his) – Canadian Blood Services
### he/him/his @@@ Katy Davison, MSc (she/her/hers) – Blood Safety, UK Health Security Agency London, England, United Kingdom ### 837496###Speaker###Principal Scientist Epidemiology###Blood Safety, UK Health Security Agency London, England, United Kingdom###Speaker: Katy Davison, MSc (she/her/hers) – Blood Safety, UK Health Security Agency London, England, United Kingdom
### she/her/hers @@@ Joanne Pink, MD, FRCPA, FRACP – Australian Red Cross Lifeblood ### 1765585###Speaker###Chief Medical Officer###Australian Red Cross Lifeblood###Speaker: Joanne Pink, MD, FRCPA, FRACP – Australian Red Cross Lifeblood
### @@@ Mindy Goldman, MD, FRCPC (she/her/hers) – Canadian Blood Services ### 2118683###Speaker###Medical Director###Canadian Blood Services###Speaker: Mindy Goldman, MD, FRCPC (she/her/hers) – Canadian Blood Services
### she/her/hers AM24-SN-21-LProgram Chair: D. Joe Chaffin, MD – Loma Linda University
### @@@ Sue T. Johnson, MSTM, MLS(ASCP)SBBCM – Versiti ### 1762728###Speaker###Director, Clinical Education###Versiti###Speaker: Sue T. Johnson, MSTM, MLS(ASCP)SBBCM – Versiti
### @@@ Meghan Delaney, DO, MPH – Childrens National Hospital ### 832724###Speaker###Chief, Pathology & Laboratory Medicine###Childrens National Hospital###Speaker: Meghan Delaney, DO, MPH – Childrens National Hospital
### @@@ Kevin J. Land, MD – Vitalant ### 837509###Speaker###VP Clinical Services###Vitalant###Speaker: Kevin J. Land, MD – Vitalant
### AM24-TU-04-LProgram Chair: Patricia Brunker, MD, DPhil (she/her/hers) – Massachusetts General Hospital
### she/her/hers @@@ Richard L. Haspel, MD, PhD (he/him/his) – Beth Israel Deaconess Medical Center and Harvard Medical School ### 837473###Speaker###Professor of Pathology###Beth Israel Deaconess Medical Center and Harvard Medical School###Speaker: Richard L. Haspel, MD, PhD (he/him/his) – Beth Israel Deaconess Medical Center and Harvard Medical School
### he/him/his @@@ Yvette M. Miller, MD, ABIHM (she/her/hers) – American Red Cross ### 832697###Speaker###Executive Medical Officer###American Red Cross###Speaker: Yvette M. Miller, MD, ABIHM (she/her/hers) – American Red Cross
### she/her/hers AM24-SN-14-LProgram Chair: Leslie Riggs, MS, MT (ASCP), SBB – Armed Services Blood Program
### @@@ Mary Ann Spott, PhD, MPA, MSIS, MBA (she/her/hers) – Defense Health Agency, J-3/5/7, Armed Services Blood Program Division (ASBPD) ### 2364559###Speaker###Deputy Division Chief, ASBPD###Defense Health Agency, J-3/5/7, Armed Services Blood Program Division (ASBPD)###Speaker: Mary Ann Spott, PhD, MPA, MSIS, MBA (she/her/hers) – Defense Health Agency, J-3/5/7, Armed Services Blood Program Division (ASBPD)
### she/her/hers AM24-SN-07-LPresenting Author: Nareg Roubinian, MD, MPHTM – Kaiser Permanente Northern California Division of Research
### OA2-AM24-ST-26